U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
176131176131Comparison of Tendon Transfer, Botox Injections and Ongoing Treatment in Hemiplegic Cerebral PalsyTerminatedNo Results AvailableCerebral PalsyProcedure: Upper Extremity Tendon transfer|Procedure: Botulinum Toxin injections in Upper Extremity|Procedure: Regularly ongoing therapyhttps://ClinicalTrials.gov/show/NCT00250081
176132176132Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)CompletedNo Results AvailableLung Diseases|CancerDrug: Liposomal 9-Nitrocamptothecinhttps://ClinicalTrials.gov/show/NCT00250068
176133176133Non-Invasive, Real-Time Technology for Diagnosis of Cervical TissueActive, not recruitingNo Results AvailableCervix|CancerProcedure: Colposcopy, Spectroscopy, and Biopsyhttps://ClinicalTrials.gov/show/NCT00250055
176134176134A Phase II Study of Gleevec and Arsenic Trioxide in Patients With CML Who Fail GleevecCompletedNo Results AvailableLeukemia, Other|CancerDrug: Gleevec and Arsenic Trioxidehttps://ClinicalTrials.gov/show/NCT00250042
176135176135Gene Expression Analysis of Patients With Metastatic Colorectal Cancer Receiving Oxaliplatin Based Chemotherapy RegimenCompletedNo Results AvailableColonic Diseases|CancerDrug: Oxaliplatinhttps://ClinicalTrials.gov/show/NCT00250029
176136176136Pharmacology Study of Aerosolized Liposomal 9-Nitro-20 (S)-Camptothecin (L9NC)CompletedNo Results AvailableCorpus Uteri|Endometrial Cancerhttps://ClinicalTrials.gov/show/NCT00250016
176137176137Preventive Home Visits for Healthy Pensioners- a Randomized Controlled TrialCompletedNo Results AvailablePrevention|House CallsBehavioral: Preventive home visitshttps://ClinicalTrials.gov/show/NCT00250003
176138176138Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)CompletedNo Results AvailableCorpus Uteri|Endometrial CancerDrug: 9-NC in aerosol reservoirhttps://ClinicalTrials.gov/show/NCT00249990
176139176139Phase I Study of Capecitabine in Combination With Cisplatin and IrinotecanCompletedNo Results AvailableSolid Tumors|CancerDrug: Capecitabine in Combination with Cisplatin and Irinotecanhttps://ClinicalTrials.gov/show/NCT00249977
176140176140Combination Paclitaxel, Carboplatin and TemozolomideCompletedNo Results AvailableLung Diseases|CancerDrug: Combination Paclitaxel, Carboplatin and Temozolomidehttps://ClinicalTrials.gov/show/NCT00249964
176141176141Alkaline Citrate Treatment to Lower the Risk of Nephrocalcinosis in Preterm InfantsCompletedNo Results AvailableNephrocalcinosisDrug: Alkaline citratehttps://ClinicalTrials.gov/show/NCT00249951
176142176142Evaluation of Combination Cholesterol Treatments in Patients With High Cholesterol.CompletedNo Results AvailableHyperlipidemia|DyslipidemiaDrug: Minute Maid Heart Wise orange juice|Drug: Welcholhttps://ClinicalTrials.gov/show/NCT00249938
176143176143Project ABLE:Advancing Better Living for EldersActive, not recruitingNo Results AvailableFrail ElderlyBehavioral: Home-Based Intervention|Behavioral: Multi-component home-based interventionhttps://ClinicalTrials.gov/show/NCT00249925
176144176144Efficacy of Lapaquistat Acetate Alone or Combined With Rosuvastatin in Subjects With HypercholesterolemiaCompletedNo Results AvailableHypercholesterolemiaDrug: Lapaquistat acetate and rosuvastatin|Drug: Lapaquistat acetate and rosuvastatin|Drug: Rosuvastatinhttps://ClinicalTrials.gov/show/NCT00249912
176145176145Efficacy of Lapaquistat Acetate Alone or Combined With High-Dose Statin Therapy in Subjects With HypercholesterolemiaTerminatedNo Results AvailableHypercholesterolemiaDrug: Lapaquistat acetate and stable statin therapy|Drug: Stable statin therapyhttps://ClinicalTrials.gov/show/NCT00249899
176146176146Discontinuation Study Of Citalopram (Antidepressant) in Depressed AdolescentsWithdrawnNo Results AvailableMajor DepressionDrug: Citalopramhttps://ClinicalTrials.gov/show/NCT00249886
176147176147Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE A)CompletedHas ResultsAtrial Fibrillation|Vascular RiskDrug: clopidogrel (SR25990C)|Drug: placebohttps://ClinicalTrials.gov/show/NCT00249873
176148176148A Multicenter Phase 3 Study of Interferon-beta-1a for the Treatment of Chronic Hepatitis C in Asian SubjectsCompletedNo Results AvailableHepatitis CDrug: Interferon-beta-1a|Drug: Placebo|Drug: Ribavirin plus Interferon-beta-1ahttps://ClinicalTrials.gov/show/NCT00249860
176149176149Study of PET Scans and Serotonin in Hot Flashes TreatmentTerminatedNo Results AvailableHot FlashesDrug: Paroxetine controlled-release|Drug: Conjugated equine estrogenhttps://ClinicalTrials.gov/show/NCT00249847
176150176150Safety and Efficacy of a Pre-defined, Fixed Dose of Gonal-f Pen Based on Subject Baseline Characteristics in Subjects Undergoing IVFCompletedNo Results AvailableInfertilityOther: CONSORT calculatorhttps://ClinicalTrials.gov/show/NCT00249834
176151176151Optimization of the Dosage Regimen of Growth Hormone Therapy in Children Born Small for Gestational AgeCompletedHas ResultsSmall for Gestational Age (SGA)Drug: Saizen®|Drug: Saizen®https://ClinicalTrials.gov/show/NCT00249821
176152176152A Study of Efalizumab in Patients With Moderate to Severe Chronic Psoriasis Who Have Failed, Have a Contraindication to, or Are Intolerant of Other Systemic TherapiesCompletedNo Results AvailablePsoriasisDrug: Efalizumab - anti CD11a recombinant human monoclonal antibodyhttps://ClinicalTrials.gov/show/NCT00249808
176153176153Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events (ACTIVE I)CompletedHas ResultsAtrial Fibrillation|Cardiovascular DiseaseDrug: Irbesartan|Drug: placebohttps://ClinicalTrials.gov/show/NCT00249795
176154176154A Phase II, Randomized Study of ACZONE™ (Dapsone) Gel, 5% for Papulopustular Rosacea.CompletedNo Results AvailableRosaceaDrug: Vehicle control, 2x/day|Drug: ACZONE (dapsone) Gel, 5%, 2x/day|Drug: ACZONE (dapsone) Gel, 5%, 1x/day|Drug: MetroGel® (metronidazole gel), 1.0% 1x/day|Drug: ACZONE (dapsone) Gel, 5%, 1x/day (AM) + MetroGel (metronidazole gel), 1.0%, 1x/day (PM)https://ClinicalTrials.gov/show/NCT00249782
176155176155Determining Safety and Efficacy of Japanese Encephalitis Vaccine When Given With Measles VaccineCompletedNo Results AvailableEncephalitis, Japanese BBiological: Japanese Encephalitis Live Attenuated SA 14-14-2 Vaccinehttps://ClinicalTrials.gov/show/NCT00249769
176156176156Re-Entry MTC for Offenders With MICA DisordersCompletedNo Results AvailableMental Disorders|Substance-Related DisordersBehavioral: Re-entry Modified Therapeutic Community (Re-entry MTC)|Behavioral: Parole Supervision and Case Managementhttps://ClinicalTrials.gov/show/NCT00249756
176157176157Clinical Evaluation of a Wireless Monitoring Device to Reduce Falls in the Elderly and Others at High Risk of FallingCompletedNo Results AvailableAccidental Falls|Fractures|InjuriesDevice: FallSaver (formerly called NOCwatch)https://ClinicalTrials.gov/show/NCT00249743
176158176158Titration Study to Evaluate Efficacy and Satisfaction of Viagra in Men With Erectile Function.CompletedNo Results AvailableImpotenceDrug: Sildenafilhttps://ClinicalTrials.gov/show/NCT00249730
176159176159Group-Based Contingency Management for Substance Abuse Treatment - 1CompletedNo Results AvailableSubstance AbuseBehavioral: Contingency managementhttps://ClinicalTrials.gov/show/NCT00249717
176160176160Randomized Study Of Exercise And Vitamin D In Frail Elderly SubjectsTerminatedNo Results AvailableElderly, FrailDrug: Vitamin D + Sham Exercise|Procedure: Vitamin D Placebo + Exercise|Procedure: Vitamin D Placebo + Sham Exercise|Drug: Vitamin D + Exercisehttps://ClinicalTrials.gov/show/NCT00249704

* Görseller ve İçerik tekif hakkına sahip olabilir